GSE125014 enzalutamide prostate gland 6 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE125014_enzalutamide_prostate gland_6_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE125014_enzalutamide_prostate gland_6_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE125014_enzalutamide_prostate gland_6_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE125014_enzalutamide_prostate gland_6_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

H2B clustered histone 8

Gene

G protein signaling modulator 3

Gene

H3.3 histone A

Gene

H2A clustered histone 19

Gene

H3.7 histone (putative)

Gene

CASTOR family member 3, pseudogene

Gene

CENPB DNA-binding domains containing 2, pseudogene

Gene

notch 2 N-terminal like B

Gene

H3 clustered histone 6

Gene

long intergenic non-protein coding RNA 649

  • Gene

    H2B clustered histone 8


  • Gene

    G protein signaling modulator 3



  • Gene

    H2A clustered histone 19


  • Gene

    H3.7 histone (putative)


  • Gene

    CASTOR family member 3, pseudogene


  • Gene

    CENPB DNA-binding domains containing 2, pseudogene


  • Gene

    notch 2 N-terminal like B


  • Gene

    H3 clustered histone 6


  • Gene

    long intergenic non-protein coding RNA 649

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.